- Home
- OCS vs GENI Comparison
OCS vs GENI Comparison
Compare OCS & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | GENI |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | Switzerland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OCS | GENI |
|---|---|---|
| Price | $12.71 | $7.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | ★ $42.00 | $12.75 |
| AVG Volume (30 Days) | 280.4K | ★ 7.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $466.06 | $24.00 |
| Revenue Next Year | $479.73 | $20.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.52 | $3.83 |
| 52 Week High | $34.48 | $13.73 |
Technical Indicators
Market Signals| Indicator | OCS | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 57.69 |
| Support Level | $10.63 | $5.69 |
| Resistance Level | $14.35 | $11.52 |
| Average True Range (ATR) | 0.59 | 0.50 |
| MACD | 0.32 | 0.05 |
| Stochastic Oscillator | 79.22 | 54.64 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.